Dear Gifted Market Watcher,
Imagine this: a paralyzed man is suddenly able to move a computer cursor, open his e-mail and control a TV simply by thinking about doing it. For 25-year-old Matthew Nagel, it was a miracle come true.
For your average investor, the whole story just may be too damn much. Then again...
At the intersection of Wall Street and science fiction stands the most gifted profit seeker -- the guy with guts, vision and intensity. If you fit this description to a T, you'll definitely want to read the next page and a half.
The cell phone-size system (including a brain-implanted microchip) that this company has been clinically testing since 2003 is also an investor's dream.
With three other patients involved in similar clinical trials, stories like Matthew's will continue to rock the media -- potentially driving up the stock 15%, 20% or even 50% over the next 12 months.
In fact, WIRED magazine has already ranked its technology as one of the top five scientific and technical discoveries in its 'Biggest Discoveries of 2005' issue.
But get this: the company's market cap is a micro $36 million.
Now this company may be tiny, but its partners are giants in the field: Brown University, Stanford University, Rhode Island Hospital, the Massachusetts General Hospital, the Spaulding Rehabilitation Center, the Sargent Rehabilitation Center, the Rehabilitation Institute of Chicago and the University of Chicago.
We're talking about leading scientists and doctors putting their reputations on the line to work with a company with a double-digit market cap.
And I am putting my reputation on the line by writing you today.
You see, after 18 years in financial publishing, I'm not easily impressed.
Of course, every now and then I come across a company and a technology that seems to have it all- a company that makes you drop everything to find out whatever you possibly can about it. And for me it's this microcap company.
That's why my goal today is to remove every single obstacle that prevents you from finding out more about this micro-giant of an investment. So for only $4.95, you can purchase the Taipan Group's Special Report that details this miraculous opportunity, and we'll throw in emailed updates on your position as well.
For $4.95 today, you stand to gain 50% within the next 24 months.
What's there to think about?
Just click here to get your Taipan Group Special Report IMMEDIATELY.
OR
For an even better deal, get all of the Special Reports from Taipan for FREE, as well as our monthly newsletter full of exciting recommendations, Buy/Sell e-alerts, a Weekly Round-Up and much more. You can receive all of this for the low price of only $39 for your subscription to Taipan! Learn more about this very special offer...
J. Christoph Amberger
Executive Publisher of the Taipan Group
P.S. I'm also preparing another Special Report on a company battling a stealth killer in China that takes 400,000 lives each year. When I read the original German version of the report on this company, I couldn't believe my eyes when I saw the size of the opportunity. I'll give you a hint: the Chinese government has committed to spending $40 billion in this market -- and this company has already won a huge high-profile contract.
If you sign up now for the Report on this microcap miracle maker, I'll guarantee that you receive this second Special Report ASAP -- for the same $4.95. At these prices, I may have to limit quantities, so it's vital that you act immediately. Order NOW!
OR
For an even better deal, get all of the Special Reports from Taipan for FREE, as well as our monthly newsletter full of exciting recommendations, Buy/Sell e-alerts, a Weekly Round-Up and much more. You can receive all of this for the low price of only $39 for your subscription to Taipan! Learn more about this very special offer... |